ESR1 and breast carcinoma: These data clearly suggest that TAp63 isoform plays a fundamental role in making aggressive breast cancer phenotypes more sensitive to hormone therapy, likely making them dependent on estrogen pathway through the up-regulation of ER-α in basal cancer.